White & Case represented Colonnade, while Latham & Watkins represented Plastiq in the transaction. Colonnade Acquisition Corp. II, a special purpose acquisition company (NYSE: CLAA), announced...
Colonnade Acquisition Corp. II’s Business Combination with Plastiq
Aramco’s $2.65 Billion Acquisition of the Global Products Business of Valvoline
White & Case advised Aramco, while Cravath, Swaine & Moore advised Valvoline on the deal. Aramco, one of the world’s largest integrated energy and chemical companies,...
Ara Partners’ Acquisition of Genera Energy
Paul Hastings advised Genera Energy on the deal, while White & Case advised Ara Partners. Genera Energy, the largest integrated manufacturer of non-wood agricultural pulp and...
HighPost Capital’s Acquisition of Centr and Inspire Fitness
White & Case LLP has advised HighPost Capital on the del. HighPost Capital, a leading private investment firm focused on the global consumer and consumer technology...
Lottery.com’s Business Combination With Trident Acquisitions
White & Case has advised Lottery.com on the deal. Lottery.com, a leading technology company that is transforming how, where and when lottery is played, executed its...
Macquarie Infrastructure Partners’ Acquisition Of Lakeshore Recycling Systems
White & Case LLP has advised Macquarie Infrastructure Partners on the deal. Macquarie Infrastructure Partners acquired Lakeshore Recycling Systems, the largest private waste company in Illinois,...
Summa Equity’s Acquisition of Axion BioSystems
Jones Day advised Axion Biosystems, Inc., while White & Case advised Summa Equity on the deal. Summa Equity Fund II (“Summa”) has acquired a majority stake...
Ivanhoe’s Business Combination With SES
Kirkland & Ellis advised Ivanhoe Capital Acquisition Corp., while White & Case and Conyers advised SES Holdings Pte. Ltd. in the transaction. Ivanhoe Capital Acquisition Corp.,...
CM Life Sciences II’s Business Combination with SomaLogic
White & Case LLP advised CM Life Sciences II, while Reed Smith advised SomaLogic on the deal. CM Life Sciences II, a special purpose acquisition company...